MFG
WST icon

Magnus Financial Group’s West Pharmaceutical WST Stock Holding History

Magnus Financial Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,458
Closed -$558K – 644
2020
Q2 		$558K Sell
2,458
-55
-2% -$10.8K 0.06% 138
2020
Q1 		$383K Buy
2,513
+32
+1% +$4.92K 0.05% 200
2019
Q4 		$373K Hold
2,481
– – 0.05% 223
2019
Q3 		$352K Hold
2,481
– – 0.07% 193
2019
Q2 		$310K Hold
2,481
– – 0.06% 234
2019
Q1 		$273K Hold
2,481
– – 0.06% 279
2018
Q4 		$243K Buy
+2,481
New +$269K 0.06% 271

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Magnus Financial Group's WST Position: Q3 2020 in Review

Magnus Financial Group sold out of West Pharmaceutical (WST) in Q3 2020, closing a stake of 2,458 shares — an estimated $558K sold.

Magnus Financial Group first reported a position in WST in Q4 2018 and held it in 7 quarters. The position peaked at $558K in Q2 2020. 574 funds tracked by Wall St. Rank hold WST as of Q3 2020.

  • Magnus Financial Group reported no remaining West Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • Magnus Financial Group sold 2,458 West Pharmaceutical shares in Q3 2020, an estimated $558K.
  • Magnus Financial Group first reported a position in West Pharmaceutical in Q4 2018 and held it in 7 quarters.
  • Magnus Financial Group's West Pharmaceutical position peaked at $558K in Q2 2020.
  • 574 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on Magnus Financial Group's 13F filing for Q3 2020, filed 5 Nov 2020.